Published in Environ Res on December 01, 1979
Protein synthesis in Escherichia coli during recovery from exposure to low levels of Cd2+. Appl Environ Microbiol (1984) 1.32
Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet (1997) 2.33
Epirubicin in extensive small-cell lung cancer: a phase II study in previously untreated patients: a National Cancer Institute of Canada Clinical Trials Group Study. J Clin Oncol (1990) 1.16
Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer. J Clin Oncol (1990) 1.13
Antimicrobial activity of diterpenoids from hairy roots of Salvia sclarea L.: salvipisone as a potential anti-biofilm agent active against antibiotic resistant Staphylococci. Phytomedicine (2005) 1.03
Phase I-II study of high-dose epirubicin in advanced non-small-cell lung cancer. J Clin Oncol (1992) 0.91
Blood coagulation changes in rats poisoned with methylmercuric chloride (MeHg). Pol J Pharmacol Pharm (1990) 0.87
Content of mercury in chromatin and level of metallothionein proteins in kidneys and liver of rats. Biochem Pharmacol (1981) 0.81
Cyclin D1 protein and CCND1 gene expression in colorectal cancer. Eur J Surg Oncol (2005) 0.80
Effect of mercuric chloride on cultured rat fibroblasts: survival, protein biosynthesis and binding of mercury to chromatin. Biochem Pharmacol (1983) 0.80
Chicken reticulocyte nuclear antigen: its identification and relation to transcriptive activity in erythropoietic cells. Biochemistry (1980) 0.80
Usefulness of polyclonal antibodies raised against P65 oncofetal protein in immunohistochemical diagnosis of ductal breast cancer. J Exp Clin Cancer Res (2004) 0.80
Coagulation and fibrinolysis in rats poisoned with mercuric chloride. Pol J Pharmacol Pharm (1989) 0.80
Expression of p65, DD3 and c-erbB2 genes in prostate cancer. Neoplasma (2003) 0.80
Monoclonal antibodies against histone H5. Epitope mapping and binding to chromatin. J Biol Chem (1985) 0.79
p65 and c-erbB2 genes expression in breast tumors: comparison with some histological typing, grading and clinical staging. J Exp Clin Cancer Res (2003) 0.79
VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer. Eur J Cancer (1994) 0.78
A phase II study of recombinant tumor necrosis factor in renal cell carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group. J Immunother (1991) (1992) 0.78
Phase II trials of trimetrexate in advanced adult soft tissue sarcoma. Studies of the Canadian Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group. Ann Oncol (1991) 0.78
Procoagulant activity of human stomach and colon cancers. Oncology (1990) 0.77
A phase II study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma. An NCI Canada Clinical Trials Group Study. Invest New Drugs (1988) 0.76
Vulvar sarcoma: a report of four cases. Gynecol Oncol (1992) 0.75
Fibrinolytic inhibitors from the experimental rat epithelioma. Thromb Res (1989) 0.75
A 65 kDa oncofetal protein (p65), proliferating cell nuclear antigen (PCNA) and Ki67 expression in breast cancer patients. Neoplasma (1998) 0.75
Non-histone chromatin proteins during maturation of avian erythroid cells. Acta Biochim Pol (1976) 0.75
5-Fluorouracil with folinic acid is not effective against metastatic adenocarcinoma of the lung. Cancer Invest (1990) 0.75
Scanning electron microscopic study on the influence of mercury compounds on the rat erythrocytes. Acta Med Pol (1980) 0.75
YMn2Hx and RMn(2-y)Fe(y)H6 (R = Y, Er) studied by Raman, infrared and inelastic neutron scattering spectroscopies. Faraday Discuss (2011) 0.75
Plasminogen activator (PA) in Guerin epithelioma. Additional PA inhibitor in plasma of rats bearing the epithelioma. Neoplasma (1990) 0.75
Plasma and platelet fibrin-stabilizing factor activity in rats intoxicated with phenylmercuric acetate. Pol J Pharmacol Pharm (1985) 0.75
[Specific inhibitors of plasminogen activators]. Postepy Hig Med Dosw (1993) 0.75
Phase II study of 2'-deoxycoformycin in patients with renal cell carcinoma. A National Cancer Institute of Canada Clinical Trials Group study. Invest New Drugs (1991) 0.75
Expression of 65-kDa oncofetal protein in experimental hepatoma after anticancer therapy. Neoplasma (1997) 0.75
Structural and magnetic properties of DyMn(2)D(6) synthesized under high deuterium pressure. J Phys Condens Matter (2008) 0.75
Formation of hydrides in (Ti(1-x)Zr(x))Co(2.00) (0 < x < 1) pseudobinary alloys. Inorg Chem (2009) 0.75
[Pulmonary emboli during tropical pyomyositis. Proposal of a preventive treatment]. Nouv Presse Med (1977) 0.75
Effect of methylmercuric chloride (MMC) on fibrin polymerization. Biol Trace Elem Res (1993) 0.75
Fibrinolytic activity of rat plasma during development of Guerin epithelioma. Cancer Lett (1990) 0.75
Activation of circulating platelets and platelet response to activating agents in children with cyanotic congenital heart disease: their relevance to palliative systemic-pulmonary shunt. Int J Cardiol (2001) 0.75
Do determinants of platelet function co-segregate with genetic markers of type 1 diabetes mellitus? Platelets (1999) 0.75
Immunospecificity of nuclear antigens in chicken erythroid cells. Mol Cell Biochem (1980) 0.75
[The mitochondrial deoxyribonucleic acid]. Postepy Biochem (1966) 0.75
Low molecular weight fibrinolytic inhibitor from Guerin epithelioma. Cancer Lett (1989) 0.75
[Fast-acting plasminogen activator inhibitor in the plasma]. Postepy Hig Med Dosw (1989) 0.75
Malignant cystosarcoma phyllodes: A review of the clinical experience at King Faisal Specialist Hospital and Research Centre. Ann Saudi Med (1994) 0.75
[Plasminogen activator inhibitors from neoplastic tissues]. Postepy Hig Med Dosw (1991) 0.75
Interaction of fibrinogen with mercury. Thromb Res (1983) 0.75
Proteolytic degradation of histones of ox pancreas. Bull Acad Pol Sci Biol (1977) 0.75
[Plasminogen activators in tumor tissue]. Pol Arch Med Wewn (1989) 0.75
Studies on histones and nuclear phosphoproteins of rat liver and Morris hepatoma. Acta Biochim Pol (1976) 0.75
Blood coagulation changes in rats during development of epithelioma. Neoplasma (1989) 0.75
Activity of neutral chromatin protease during maturation of chicken erythroid cells. Biochimie (1976) 0.75
Uptake of radiolabeled morphiceptin and its analogs by experimental mammary adenocarcinoma: in vitro and in vivo studies. Nucl Med Biol (2004) 0.75
Cancer procoagulant in serum of rats during development of experimental epithelioma. Int J Cancer (1990) 0.75
Factor X-activating activity from Guerin epithelioma. Neoplasma (1988) 0.75
A late relapse of primary Krukenberg tumour with bone metastases. Clin Oncol (R Coll Radiol) (2003) 0.75
Culture of Hansen's bacilli in vitro in a case of lepromatous leprosy. Mater Med Pol (1978) 0.75
Selective extraction of histones from normal and irradiated calf lymph-nodes. Int J Radiat Biol Relat Stud Phys Chem Med (1971) 0.75